The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Celgene; Lilly; Merck; Pfizer
Research Funding - AstraZeneca; Atara Biotherapeutics; Blueprint Medicines; Bristol-Myers Squibb; Celgene; Cellceutix; Celldex; Enzychem Lifesciences; Exelixis; Gliknik; Innate Pharma; Kura Oncology; Lilly; Matrix Biomed; MedImmune; Merck; Novartis; Pfizer; Polaris
Travel, Accommodations, Expenses - Pfizer
 
Speakers' Bureau - Bristol-Myers Squibb

Palbociclib plus cetuximab versus placebo plus cetuximab in platinum-resistant, cetuximab-naive, HPV-unrelated head and neck cancer: A double-blind randomized phase II trial (PALATINUS).
 
Douglas Adkins
No Relationships to Disclose
 
Jin-Ching Lin
No Relationships to Disclose
 
Assuntina Gesualda Sacco
Honoraria - Onclive
Research Funding - inVentiv Health (Inst); Merck (Inst); Pfizer/EMD Serono (Inst)
 
Jessica C. Ley
No Relationships to Disclose
 
Peter Oppelt
No Relationships to Disclose
 
Qi Shen
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Kenneth Alan Kern
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Holger C. Thurm
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Shaw-Ling Wang
Stock and Other Ownership Interests - Pfizer
 
Jean-Francois Martini
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Justin Hoffman
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Bohuslav Melichar
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Janssen; Merck Serono; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi; SERVIER
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Pfizer; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Serono; Novartis
 
Makoto Tahara
Honoraria - AstraZeneca; Bristol-Myers Squibb; Eisai; Merck Serono; MSD; Ono Pharmaceutical
Consulting or Advisory Role - Amgen; Aspyrian Therapeutics; Bristol-Myers Squibb; Celgene; MSD; Ono Pharmaceutical; Pfizer
Research Funding - Aspyrian Therapeutics (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Loxo (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst)